newsfilter
← Latest News
PR Newswire·

NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe...